ARCHIVES

NCI, NHGRI plan $100-million, three-year feasibility test for cancer genome project. NCI to establish biospecimen office.

This article is from The Cancer Letter archive.

Vol. 31 No. 34 | September 23, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Designates Zometa For Priority Review.

November 30, 2001

“Imaginary Treatments,” “Wonderful Cures”

June 6, 1997

NCI Critics Take Their Best Shots, Seek New Emphasis On Prevention At Kennedy Hearings

March 16, 1979

Anna Barker Named Deputy Director for Strategic Scientific Initiatives

December 6, 2002

Realities Of The 1989 Budget: Number Of grants Cut By 250, Only 255 Of Approved Will By Funded

October 7, 1988

FDA Clears Rapid Test For Aspergillus Infection

May 30, 2003